P. Palmer

发表

Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and non-viral inducing factors.

R. Porcher, P. Lebon, M. Tovey, 2007, European cytokine network.

Multicenter evaluating of a commercially available PCR assay for diagnosing enterovirus infection in a panel of cerebrospinal fluid specimens

B. Masquelier, H. Fleury, J. Puel, 1996, Journal of clinical microbiology.

FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus.

B. Weill, F. Batteux, P. Lebon, 1999, European cytokine network.

Multicenter Quality Assessment of PCR Methods for Detection of Enteroviruses

K. Korn, A. Tenório, A. Fomsgaard, 1999, Journal of Clinical Microbiology.

Ninety-six-week efficacy of combination therapy with lamivudine and tenofovir in patients coinfected with HIV-1 and wild-type hepatitis B virus.

J. Molina, C. Scieux, F. Bani-Sadr, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Procalcitonin, C-reactive protein and interleukin 6 in bacterial and viral meningitis in children].

C. Lacombe, P. Lebon, D. Gendrel, 1998, Presse medicale.

Antibody-dependent induction of type I interferons by poliovirus in human mononuclear blood cells requires the type II fcgamma receptor (CD32).

B. Rombaut, P. Lebon, M. Daëron, 2000, Virology.

Congenital HCMV infection: a collaborative and comparative study of virus detection in amniotic fluid by culture and by PCR.

P. Lebon, F. Rozenberg, F. Freymuth, 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Five-Year Follow up of Once-Daily Therapy with Emtricitabine, Didanosine and Efavirenz (Montana ANRS 091 Trial)

P. Morlat, F. Raffi, G. Chêne, 2006, Antiviral therapy.

Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HIV-1-infected adults with viral suppression receiving a protease inhibitor-based regimen: a randomized trial.

P. Morlat, W. Rozenbaum, F. Collin, 2005, The Journal of infectious diseases.

One or two enzyme-linked immunosorbent assay tests on the first serum sample for initial diagnosis of HIV-1 infection?

F. Brun-Vézinet, C. Rouzioux, D. Costagliola, 2008, AIDS.

Case report: Cure of chronic infection with hepatitis C virus after 6 weeks of peg‐interferon and ribavirin in a patient co‐infected with HIV

J. Molina, F. Simon, P. Palmer, 2010, Journal of medical virology.

Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections.

J. Coste, C. Lacombe, D. Gendrel, 1999, The Pediatric infectious disease journal.

French National Sentinel Survey of Antiretroviral Drug Resistance in Patients With HIV-1 Primary Infection and in Antiretroviral-Naive Chronically Infected Patients in 2001-2002

F. Brun-Vézinet, P. André, B. Masquelier, 2005, Journal of acquired immune deficiency syndromes.

No Evidence of Measles Virus in Stapes Samples from Patients with Otosclerosis

A. B. Grayeli, P. Tran Ba Huy, E. Ferrary, 2000, Journal of Clinical Microbiology.

Interferon‐alpha in viral and bacterial gastroenteritis: a comparison with C‐reactive protein and interleukin‐6

D. Gendrel, F. Moulin, J. Raymond, 1999, Acta paediatrica.

Virological and Pharmacological Parameters Predicting the Response to Lopinavir-Ritonavir in Heavily Protease Inhibitor-Experienced Patients

V. Calvez, D. Kempf, M. King, 2005, Antimicrobial Agents and Chemotherapy.

Spontaneous recovery of opsoclonusmyoclonus syndrome caused by enterovirus infection

P. Lebon, G. Sébire, B. Tabarki, 1998, Journal of neurology, neurosurgery, and psychiatry.

Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era

F. Barbier, É. Azoulay, B. Schlemmer, 2010, Critical care.

Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy.

V. Calvez, G. Chêne, L. Cotte, 2007, AIDS research and human retroviruses.

Genotypic Determinants of the Virological Response to Tenofovir Disoproxil Fumarate in Nucleoside Reverse Transcriptase Inhibitor-Experienced Patients

F. Brun-Vézinet, B. Masquelier, D. Costagliola, 2003, Antiviral therapy.

Interruptions du traitement antirétroviral chez 30 patients infectés par le VIH en succès virologique

R. Porcher, S. Fournier, J. Molina, 2005 .

[Acyclovir-resistance zona in a immunocompromised HIV seronegative patient].

J. Huraux, D. Bouscary, D. Salmon-Céron, 1998, Annales de dermatologie et de venereologie.

Pattern and impact of emerging resistance mutations in treatment experienced patients failing darunavir-containing regimen

C. Delaugerre, S. Blanche, J. Molina, 2008, AIDS.

First-line use of enfuvirtide-containing HAART regimen with dramatic clinical and immunological improvement in three cases.

D. Farge, E. Tuleja, D. Séréni, 2006, AIDS.

Case report: Cure of chronic infection with hepatitis C virus after 6 weeks of peg‐interferon and ribavirin in a patient co‐infected with HIV

J. Molina, F. Simon, P. Palmer, 2010, Journal of medical virology.